Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
35 studies found for:    "Pars planitis"
Show Display Options
RSS Create an RSS feed from your search for:
"Pars planitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Myfortic for the Treatment of Non-infectious Intermediate Uveitis
Condition: Non-infectious Intermediate Uveitis
Interventions: Drug: Myfortic;   Drug: Decortin
2 Active, not recruiting Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis;   Noninfectious Uveitis
Intervention: Drug: triamcinolone acetonide (Triesence®)
3 Completed
Has Results
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis
Conditions: Intermediate Uveitis;   Posterior Uveitis
Interventions: Drug: Dexamethasone;   Drug: dexamethasone;   Drug: Sham injection
4 Unknown  Intravitreal Sirolimus as Therapeutic Approach to Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
Interventions: Drug: Intravitreal injection 440mcg;   Drug: Intravitreal injection of sirolimus 880mcg
5 Unknown  Sirolimus as Therapeutic Approach to Uveitis
Conditions: Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Panuveitis
Intervention: Drug: Sirolimus (rapamycin)
6 Recruiting Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Interventions: Drug: FAI insert;   Drug: Sham injection
7 Completed Retisert and Cataract Surgery in Patients With Severe Uveitis
Conditions: Intermediate Uveitis;   Posterior Uveitis
Intervention: Device: Retisert (fluocinolone acetonide implant)
8 Completed Quality of Life in Patients With Intermediate Uveitis
Condition: Macular Edema
Intervention:
9 Completed Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis
Conditions: Uveitis, Intermediate;   Macular Edema;   Multiple Sclerosis
Interventions: Drug: Interferon beta;   Drug: Methotrexate
10 Recruiting Safety, Tolerability and Efficacy of Intravitreal LFG316 in Patients With Multifocal Choroiditis and Panuveitis (MCP)
Conditions: Multifocal Choroiditis;   Panuveitis;   Active Vitritis
Interventions: Drug: LFG316;   Drug: Conventional Therapy
11 Completed Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis
Conditions: Uveitis;   Posterior Uveitis;   Panuveitis
Intervention: Drug: AEB071
12 Completed Vascular Endothelial Growth Factor (VEGF) in Uveitis
Conditions: Macular Edema, Cystoid;   Uveitis
Intervention:
13 Enrolling by invitation The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
Conditions: Uveitis;   Vasculitis;   Ocular Inflammatory Disease
Intervention:
14 Recruiting Immunogenetic Mechanisms in Behcet's Disease
Conditions: Behcet's Disease;   Uveitis
Intervention:
15 Recruiting Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
Conditions: Uveitis;   Macular Edema;   Uveitis, Posterior;   Uveitis, Anterior;   Panuveitis;   Uveitis, Intermediate
Interventions: Drug: 4 mg CLS-TA;   Drug: 0.8 mg CLS-TA
16 Terminated Safety and Efficacy of AIN457 in Behçet's Patients With Posterior or Panuveitis
Condition: Uveitis
Interventions: Biological: AIN457;   Drug: Placebo
17 Withdrawn A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis
Condition: Uveitis
Intervention: Device: Iontophoresis second generation Eyegate II device
18 Completed Human Samples and Data Repository
Conditions: Uveitis;   Scleritis
Intervention:
19 Terminated Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis Study
Condition: Non-infectious Uveitis
Interventions: Biological: AIN457;   Drug: Placebo
20 Enrolling by invitation A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
Condition: Uveitis
Intervention: Drug: adalimumab

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years